HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dieter Hörsch Selected Research

Radioisotopes (Radionuclides)

1/2021Prior Resection of the Primary Tumor Prolongs Survival After Peptide Receptor Radionuclide Therapy of Advanced Neuroendocrine Neoplasms.
3/2018Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms.
1/2017ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues.
5/2016Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-up.
1/2014THERANOSTICS-clinical aimshots in surgical warfare against well-differentiated neuroendocrine neoplasms.
1/2013Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registry.
12/2009Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dieter Hörsch Research Topics

Disease

19Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2024 - 01/2005
15Neoplasms (Cancer)
01/2021 - 01/2005
11Carcinoid Tumor (Carcinoid)
01/2022 - 12/2011
9Diarrhea
01/2022 - 02/2011
4Nausea
01/2024 - 02/2011
3Flushing
01/2018 - 01/2015
2Primitive Neuroectodermal Tumors (PNET)
01/2022 - 11/2021
2Fatigue
12/2011 - 02/2011
1Thrombocytopenia (Thrombopenia)
01/2024
1Neutropenia
01/2024
1Neuroendocrine Carcinoma
03/2022
1Acromegaly
01/2019
1Leukemia
03/2018
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2018
1Weight Loss (Weight Reduction)
01/2018
1Abdominal Pain (Pain, Abdominal)
01/2018
1Weight Gain
01/2018
1Disease Progression
12/2016
1Sleep Initiation and Maintenance Disorders (Insomnia)
12/2016
1Heart Valve Diseases (Valvular Heart Disease)
04/2015
1Astrocytoma (Pilocytic Astrocytoma)
01/2013
1Breast Neoplasms (Breast Cancer)
01/2013
1Renal Cell Carcinoma (Grawitz Tumor)
01/2013
1Tuberous Sclerosis (Bourneville's Disease)
01/2013
1Angiomyolipoma
01/2013
1Carcinogenesis
01/2013
1Neoplasm Metastasis (Metastasis)
09/2012
1Aneuploidy (Aneuploid)
09/2012
1Stomatitis
12/2011
1Exanthema (Rash)
12/2011
1Vomiting
02/2011
1Asthenia
02/2011
1Endocrine Gland Neoplasms (Cancer, Endocrine)
01/2007
1Thyroid Neoplasms (Thyroid Cancer)
01/2007
1Bone Resorption
04/2006
1Vascular Calcification
04/2006
1Vascular Diseases (Vascular Disease)
04/2006
1Gastro-enteropancreatic neuroendocrine tumor
01/2005

Drug/Important Bio-Agent (IBA)

11Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2024 - 01/2015
8telotristat ethylIBA
01/2022 - 01/2017
7Peptide Receptors (Peptide Receptor)IBA
01/2021 - 12/2009
7Radioisotopes (Radionuclides)IBA
01/2021 - 12/2009
5Tryptophan HydroxylaseIBA
01/2019 - 01/2017
5Somatostatin Receptors (Somatostatin Receptor)IBA
03/2018 - 11/2011
3Octreotide (Sandostatin)FDA LinkGeneric
01/2019 - 12/2011
3Serotonin (5 Hydroxytryptamine)IBA
01/2019 - 04/2015
3EverolimusFDA Link
01/2015 - 12/2011
2Streptozocin (Streptozotocin)FDA Link
01/2022 - 09/2012
2SurvivinIBA
07/2018 - 01/2005
2Proteins (Proteins, Gene)FDA Link
07/2018 - 04/2006
2telotristatIBA
01/2018 - 04/2015
2Sunitinib (Sutent)FDA Link
12/2016 - 02/2011
2Fluorouracil (Carac)FDA LinkGeneric
09/2012 - 01/2005
2Tyrosine Kinase InhibitorsIBA
02/2011 - 01/2005
1Temozolomide (Temodar)FDA LinkGeneric
01/2024
1lanreotide (Somatuline)FDA Link
01/2024
1SynaptophysinIBA
03/2022
1Chromogranin AIBA
03/2022
1RamucirumabIBA
11/2021
1Dacarbazine (DIC)FDA LinkGeneric
11/2021
1DiphenoxylateFDA LinkGeneric
01/2019
1Loperamide (Imodium)FDA LinkGeneric
01/2019
1Cholinergic Antagonists (Anticholinergics)IBA
01/2019
1AtropineFDA LinkGeneric
01/2019
1AntibodiesIBA
07/2018
1Hydroxyindoleacetic AcidIBA
01/2018
1Acetic Acid (Vinegar)FDA LinkGeneric
01/2017
1TransferasesIBA
01/2017
15-hydroxyindoleIBA
01/2017
1Hormones (Hormone)IBA
01/2013
1Protein Kinases (Protein Kinase)IBA
01/2013
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2013
1TOR Serine-Threonine KinasesIBA
01/2013
1ErbB Receptors (EGF Receptor)IBA
01/2013
1fluorodopa F 18IBA
12/2012
1LigandsIBA
12/2012
1Aurora KinasesIBA
09/2012
1danusertibIBA
09/2012
1Gallium-68IBA
11/2011
1Cyclin EIBA
11/2008
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2007
1raf KinasesIBA
01/2007
1OsteoprotegerinIBA
04/2006
1CytokinesIBA
04/2006
1Interleukin-4 (Interleukin 4)IBA
04/2006
1InterleukinsIBA
04/2006
1Valine (L-Valine)FDA Link
02/2005
1Glutamic Acid (Glutamate)FDA Link
02/2005
1Mitogen-Activated Protein KinasesIBA
02/2005
1Ki-67 Antigen (Ki 67 Antigen)IBA
01/2005
1Imatinib Mesylate (Gleevec)FDA Link
01/2005
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2005
1Phosphotransferases (Kinase)IBA
01/2005

Therapy/Procedure

15Therapeutics
01/2024 - 12/2009
1Drug Therapy (Chemotherapy)
11/2021
1Renal Dialysis (Hemodialysis)
03/2018
1Aftercare (After-Treatment)
03/2018
1Precision Medicine
01/2014
1Conservative Treatment
09/2012
1Cell Transplantation
09/2012